Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma
NCT: NCT07837908 · NOT_YET_RECRUITING
Brief Summary
This randomized controlled prospective single-blinded comparative clinical study aims to compare the efficacy and safety of fractional carbon dioxide (CO2) laser therapy versus mechanical dermabrasion, both combined with topical 5-fluorouracil, in the treatment of acquired non-vitiligo leukoderma. The study will evaluate repigmentation, clinical improvement, patient satisfaction, and treatment-related adverse effects.
Frequently Asked Questions
What is Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma?
Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma is a clinical trial registered under NCT07837908. Current status: NOT_YET_RECRUITING.
What is the status of NCT07837908?
The current status of NCT07837908 (Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma) is: NOT_YET_RECRUITING.
When did Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma start?
Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma started on 2026-08-26.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.